| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0057 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0053 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |